2022 May 10

Registrations open for the Spetses Summer School 2022 “Cancer epigenetics: principles, applications and single-cell resolution”

Open to the scientific community, this year Spetses Summer School will cover the topics of chromatin structure, epigenetic regulation, single-cell omics, and disease applications with a particular focus on cancer and leukaemia.

 

The summer school will take place from 28 August to 3 September in the Greek island of Spetses and it is co-organized by the Innovative Training Network (ITN) INTERCEPT-MDS, co-ordinated by the Josep Carreras Leukaemia Research Institute (IJC), in collaboration with the European Hematology Association (EHA), the ITN Cell-2-cell, EpiGeneSys, LifeTime, the collaborative research center (CRC) on Chromatin Dynamics SFB 1064, and the Norwegian research network CanCell. 

The Spetses Summer School will be attended by 100 early career researchers (PhD students and junior postdocs) and 25 Principal Investigadors acting as instructors.

The confirmed speakers are:

  • Geneviève Almouzni, Paris, FR (Keynote lecture)
  • Douglas Higgs, Oxford, UK (Keynote lecture)
  • Maria Berdasco, Barcelona, ES
  • Sigurd Braun, Giessen, DE
  • Marcus Buschbeck, Barcelona, ES
  • Ana Conesa, Valencia, ES
  • Maria Colomé-Taché, Munich, DE
  • Ruud Delwel, Rotterdam, NL     
  • Ragnhild Eskeland, Oslo, NO                 
  • Jorrit Enserink, Oslo, NO
  • Katharina Goetze, Munich, DE
  • Florian Grebien, Vienna, AT      
  • Stephan Hamperl, Munich, DE
  • Raphael Itzykson, Paris, FR
  • Reini Luco, Montpellier, FR
  • Jean-Christophe Marine, Leuven, BE
  • Emmet McCormack, Bergen, NO           
  • Hind Medyouf, Frankfurt, DE
  • Alexandre Puissant, Paris, FR     
  • Valeria Santini, Florence, IT
  • Marie Schneider, Leipzig, DE
  • Sara Sdelci, Barcelona, ES
  • Stefan Stricker, Munich, DE
  • Wencke Walter, Munich, DE

Register now and send your abstract until 1st June. Participants will be selected on the basis of excellence and diversity of their submitted abstracts.

For more information, please visit: intercept-mds.eu

 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 953407.